Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

Cited by (870)

Items 401–500 of 870

1. Twenty-four hour care for schizophrenia
   Rob Macpherson, Thomas Rhys Edwards, Rupatharshini Chilvers, Chris David, Helen J Elliott · 2009 · Cochrane Database of Systematic Reviews
2. Yoga versus non-standard care for schizophrenia
   Julie M. Broderick, Niall Crumlish, Alice Waugh, Davy Vancampfort · 2017 · Cochrane Database of Systematic Reviews
3. Beta-blocker supplementation of standard drug treatment for schizophrenia
   Elena Shek, Sabyasachi Bardhan, Maxim V. Cheine, Juha Ahonen, Kristian Wahlbeck · 2001 · Cochrane Database of Systematic Reviews
4. Developing a reporting guideline for social and psychological intervention trials
   Evan Mayo‐Wilson, Paul Montgomery, Sally Hopewell, Geraldine M. Macdonald, David Moher, Sean Grant · 2013 · The British Journal of Psychiatry
5. Perphenazine for schizophrenia
   Benno Hartung, Makoto Wada, Gerd Laux, Stefan Leucht · 2005 · Cochrane Database of Systematic Reviews
6. Risperidone versus other atypical antipsychotics for schizophrenia
   Katja Komossa, Heike Hunger, Franziska Schmidt, Sandra Schwarz, Stefan Leucht, Christine Rummel‐Kluge · 2007 · Cochrane Database of Systematic Reviews
7. Open Dialogue for psychosis or severe mental illness
   Ruth Yvonne Pavlovic, Aleksandar Pavlovic, Stephen Donaldson · 2016 · Cochrane Database of Systematic Reviews
8. Yoga as part of a package of care versus non-standard care for schizophrenia
   Julie M. Broderick, Davy Vancampfort · 2017 · Cochrane Database of Systematic Reviews
9. Translation, validation and test–retest reliability of the VISA-G patient-reported outcome tool into Danish (VISA-G.DK)
   Jens Erik Jorgensen, A. Fearon, Carsten Mølgaard, Jens Kristinsson, Jane Andreasen · 2020 · PeerJ
10. Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
    Irene Bighelli, Alessandro Rodolico, Spyridon Siafis, Myrto T. Samara, Wulf‐Peter Hansen, Salvatore Salomone, Eugenio Aguglia, Pierfelice Cutrufelli, Ingrid Oliveira Bosenbecker Bauer, Lio Bäckers et al. · 2022 · Cochrane Database of Systematic Reviews
11. Antipsychotic medication versus placebo for people with both schizophrenia and learning disability
    Lorna Duggan, Jane Brylewski · 2004 · Cochrane Database of Systematic Reviews
12. A systematic review of the psychometric properties of bronchiolitis assessment tools
    Clare J. Davies, Donna Waters, Andrea P. Marshall · 2016 · Journal of Advanced Nursing
13. Treatments for primary delusional infestation
    Iyas Assalman, Alia Ahmed, Randa Alhajjar, Anthony Bewley, Ruth E. Taylor · 2019 · Cochrane Database of Systematic Reviews
14. Acupuncture for schizophrenia
    Xiaohong Shen, Jun Xia, Clive Elliott Adams · 2014 · Cochrane Database of Systematic Reviews
15. Developing a Reporting Guideline for Social and Psychological Intervention Trials
    Paul Montgomery, Evan Mayo‐Wilson, Sally Hopewell, Geraldine M. Macdonald, David Moher, Sean Grant · 2013 · American Journal of Public Health
16. Chlorpromazine versus reserpine for schizophrenia
    Selin Nur, Clive Elliott Adams · 2016 · Cochrane Database of Systematic Reviews
17. Nitric oxide, phosphodiesterase inhibition, and adaption to hypoxic conditions
    Martin R. Wilkins, Almaz A. Aldashev, Nicholas W. Morrell · 2002 · The Lancet
18. Lithium for schizophrenia
    Stefan Leucht, John Joseph McGrath, Werner Kissling · 2003 · Cochrane Database of Systematic Reviews
19. Cannabis and schizophrenia
    John Rathbone, Hannele Variend, Hetal Mehta · 2008 · Cochrane Database of Systematic Reviews
20. Statistical and methodological considerations for reporting RCTs in medical literature
    Sangseok Lee, Hyun Kang · 2015 · Korean Journal of Anesthesiology
21. Flupenthixol versus placebo for schizophrenia
    Xiaohong Shen, Jun Xia, Clive Elliott Adams · 2012 · Cochrane Database of Systematic Reviews
22. Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia
    Magdolna Tardy, Markus Dold, Rolf R. Engel, Stefan Leucht · 2014 · Cochrane Database of Systematic Reviews
23. Morita therapy for schizophrenia
    Yanling He, Chunbo Li · 2007 · Cochrane Database of Systematic Reviews
24. Psychological interventions for psychosis in adolescents
    Soumitra Shankar Datta, Rhea Daruvala, Ajit Kumar · 2020 · Cochrane Database of Systematic Reviews
25. Randomised controlled trial of Lactobacillus rhamnosus (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol
    David Schnadower, Phillip I. Tarr, Theron Charles Casper, Marc H. Gorelick, Michael J. Dean, Karen J. O’Connell, Prashant Mahajan, Thomas H. Chun, Seema R. Bhatt, Cindy Ganis Roskind et al. · 2017 · BMJ Open
26. User-held personalised information for routine care of people with severe mental illness
    Simone E. Farrelly, Gill Brown, Clare Flach, Elizabeth Alexandra Barley, Richard A. Laugharne, Claire Henderson · 2013 · Cochrane Database of Systematic Reviews
27. Levomepromazine for schizophrenia
    Parthipan Sivaraman, Ranganath D Rattehalli, Mahesh Jayaram · 2010 · Cochrane Database of Systematic Reviews
28. Aripiprazole for schizophrenia
    Hany George G El-Sayeh, Carla Morganti · 2004 · Cochrane Database of Systematic Reviews
29. A review of the content and psychometric properties of cancer-related fatigue (CRF) measures used to assess fatigue in intervention studies
    Rachel Campbell, Renée Bultijnck, Gemma Ingham, Chindhu Shunmuga Sundaram, Joshua F. Wiley, Jasmine Yee, Haryana Mary Dhillon, Joanne Shaw · 2022 · Supportive Care in Cancer
30. Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
    Alexander Hodkinson, Carl J. Heneghan, Kamal Ram Mahtani, Evangelos Kontopantelis, Maria Panagioti · 2021 · BMC Medicine
31. Children's Views on Mental Illness
    Lisetta M. Lovett, A Tamkin, J Fletcher · 2011 · International Journal of Health Promotion and Education
32. Pericyazine for schizophrenia
    Hosam E. Matar, Muhammad Qutayba Almerie, Samer Makhoul, Jun Xia, Pamela Humphreys · 2014 · Cochrane Database of Systematic Reviews
33. Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia
    Magdolna Tardy, Maximilian Huhn, Rolf R. Engel, Stefan Leucht · 2014 · Cochrane Database of Systematic Reviews
34. Applying Trial Evidence Back to the Patient
    Hywel C Williams · 2003 · Archives of Dermatology
35. Writing the Methods
    John Coverdale, Laura Weiss Roberts, Alan K. Louie, Eugene V. Beresin · 2006 · Academic Psychiatry
36. Risperidone versus placebo for schizophrenia
    Ranganath D Rattehalli, Mahesh Jayaram, Michael Smith · 2010 · Cochrane Database of Systematic Reviews
37. Gamma-aminobutyric acid agonists for neuroleptic-induced tardive dyskinesia
    John Rathbone, Jonathan James Deeks, Karla Soares‐Weiser · 2004 · Cochrane Database of Systematic Reviews
38. Asenapine versus placebo for schizophrenia
    Alistair Hay, Amy Byers, Marco Sereno, Manpreet Kaur Basra, Snigdha Dutta · 2015 · Cochrane Database of Systematic Reviews
39. Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia
    Karen Morris, Aleena Syed, Graeme S. Reid, Sally Spencer · 2016 · Cochrane Database of Systematic Reviews
40. Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia
    Samer Alabed, Youssef Latifeh, Husam Aldeen Mohammad, Hanna Bergman · 2018 · Cochrane Database of Systematic Reviews
41. Modafinil for people with schizophrenia or related disorders
    Javier Ortiz‐Orendain, Sergio Armando Covarrubias-Castillo, Alan Omar Vázquez‐Álvarez, Santiago Castiello, Gustavo E. Arias Quiñones, Maya Seegers, Luis Enrique Colunga‐Lozano · 2019 · Cochrane Database of Systematic Reviews
42. Duration of untreated psychosis
    Max Marshall, Susy Harrigan, Shôn W. Lewis · 2009 · Cambridge University Press eBooks
43. Droperidol for acute psychosis
    John Rathbone, Simone L Mandriota-Carpenter, Sharon J Cure · 2004 · Cochrane Database of Systematic Reviews
44. 'As required' medication regimens for seriously mentally ill people in hospital
    Emma Whicher, Murray Morrison, Petrina Douglas-Hall · 2002 · Cochrane Database of Systematic Reviews
45. General physical health advice for people with serious mental illness
    Graeme E Tosh, Andrew Clifton, Mick Bachner · 2011 · Cochrane Database of Systematic Reviews
46. Chlorpromazine versus clotiapine for schizophrenia
    Shahrzad Mazhari, Saeed Esmailian, Armita Shahesmaeili, Ali S. Goughari, Azam Bazrafshan, Morteza Zare · 2017 · Cochrane Database of Systematic Reviews
47. Parenting interventions for people with schizophrenia or related serious mental illness
    Jessica Radley, Claire Grant, Jane Barlow, Louise Johns · 2021 · Cochrane Database of Systematic Reviews
48. Quetiapine for psychosis-induced aggression or agitation
    Fran Wilkie, Mark Fenton · 2012 · Cochrane Database of Systematic Reviews
49. Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia
    Myrto T. Samara, Elisabeth Klupp, Bartosz Helfer, Philipp Rothe, Johannes Schneider‐Thoma, Stefan Leucht · 2018 · Cochrane Database of Systematic Reviews
50. Psychotherapy Plus Antidepressant for Panic Disorder With or Without Agoraphobia: Systematic Review
    Toshi A. Furukawa, Norio Watanabe, Rachel C. Churchill · 2008 · FOCUS The Journal of Lifelong Learning in Psychiatry
51. Zotepine versus other atypical antipsychotics for schizophrenia
    Selvizhi Subramanian, Christine Rummel‐Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Werner Kissling, Stefan Leucht, Katja Komossa · 2010 · Cochrane Database of Systematic Reviews
52. Problem solving skills for schizophrenia
    Jun Xia, Chunbo Li · 2007 · Cochrane Database of Systematic Reviews
53. Hypnosis for schizophrenia
    Angelica Izquierdo de Santiago, Mahmood Khan · 2007 · Cochrane Database of Systematic Reviews
54. Cochrane Schizophrenia Group
    Clive Elliott Adams, Evandro Silva Freire Coutinho, John M. Davis, Lorna Duggan, Stefan Leucht, Chaoyuan Li, Prathap Tharyan · 2007 · Schizophrenia Bulletin
55. Supportive therapy for schizophrenia
    Lucy A Buckley, Tor ACL Pettit, Clive Elliott Adams · 2007 · Cochrane Database of Systematic Reviews
56. Early Intervention for psychosis
    Max Marshall, Austin Lockwood · 2003
57. Risperidone versus placebo for schizophrenia
    Ranganath D Rattehalli, Mahesh Jayaram · 2008 · Cochrane Database of Systematic Reviews
58. The General Self-Efficacy Scale in a population planned for bariatric surgery in Sweden: a psychometric evaluation study
    Karuna Dahlberg, Erik Stenberg, Yuli Liang, Ulrica G. Nilsson, Maria Jaensson · 2022 · BMJ Open
59. Chlorpromazine versus piperacetazine for schizophrenia
    Mahin Eslami Shahrbabaki, Rahim Sharafkhani, Reza Dehnavieh, Leila Vali · 2015 · Cochrane Database of Systematic Reviews
60. Risperidone for psychosis induced aggression or agitation
    Uzair Ahmed, Faiz Rehman, Hannah Grace Jones, Clive Elliott Adams · 2011 · Cochrane Database of Systematic Reviews
61. Chlorpromazine versus metiapine for schizophrenia
    Morteza Zare, Azam Bazrafshan · 2017 · Cochrane Database of Systematic Reviews
62. Distraction techniques for schizophrenia
    CJ Crawford-Walker, Adrian King, Sally Wai‐Chi Chan · 2005 · Cochrane Database of Systematic Reviews
63. Perazine for schizophrenia
    Stefan Leucht, Bartosz Helfer, Benno Hartung · 2014 · Cochrane Database of Systematic Reviews
64. Assessing the overuse of antibiotics in children with URTIs in Saudi Arabia: Development of the parental perception on antibiotics scale (PAPA scale)
    Arwa Khalid Alumran, Xiang‐Yu Hou, Cameron Paul Hurst · 2013 · Journal of Epidemiology and Global Health
65. Loxapine inhaler for psychosis-induced aggression or agitation
    Rohini Vangala, Uzair Ahmed, Rais Irfan Ahmed · 2012 · Cochrane Database of Systematic Reviews
66. Haloperidol (route of administration) for people with schizophrenia
    Ibrahem Hanafi, Subhi Arafat, Lin Al Zayed, Majd Sukkar, Abdullah Albeirakdar, Dima Krayem, Adib Essali · 2017 · Cochrane Database of Systematic Reviews
67. Open general medical wards versus specialist psychiatric units for acute psychoses
    Fred W Hickling, Wendel Dwight Abel, Paul Garner, John Rathbone · 2007 · Cochrane Database of Systematic Reviews
68. Ayurvedic medicine for schizophrenia
    Vishesh Agarwal, Akhil Abhijnhan, Prakash Raviraj · 2007 · Cochrane Database of Systematic Reviews
69. Depot pipotiazine palmitate and undecylenate for schizophrenia
    M Dinesh, Anthony S. David, Seema N Quraishi · 2004 · Cochrane Database of Systematic Reviews
70. The Reliability and Validity of the Hebrew Patient Health Questionnaire (PHQ-9) in the General Population
    Tomer Yona, Asaf Weisman, Uri Gottlieb, Eshed Lin, Youssef Masharawi · 2021 · medRxiv
71. Cognitive behavioural therapy (brief versus standard duration) for schizophrenia
    Farooq Naeem, Saeed Farooq, David Kingdon · 2014 · Cochrane Database of Systematic Reviews
72. Art therapy for schizophrenia or schizophrenia-like illnesses
    Rachel Ruddy, David Milnes · 2003 · Cochrane Database of Systematic Reviews
73. HIV prevention advice for people with serious mental illness
    Nicola Wright, Athfah Akhtar, Graeme E Tosh, Andrew Clifton · 2016 · Cochrane Database of Systematic Reviews
74. Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders
    Saeed Farooq, Rupinder K Johal, Charlotte Ziff, Farooq Naeem · 2017 · Cochrane Database of Systematic Reviews
75. Association Between Diarrhea Duration and Severity and Probiotic Efficacy in Children With Acute Gastroenteritis
    David Schnadower, Karen J. O’Connell, John M. VanBuren, Cheryl Vance, Phillip I. Tarr, Suzanne Schuh, Katrina F. Hurley, Alexander Joseph Rogers, Naveen Poonai, Cindy Ganis Roskind et al. · 2020 · The American Journal of Gastroenterology
76. Quantitative Psychotherapy Outcome Research: Methodological Issues
    Christian Gold · 2014 · Springer eBooks
77. Methodological considerations in treatment evaluations of tinnitus distress: A call for guidelines
    Hugo Hesser · 2010 · Journal of Psychosomatic Research
78. Psychological interventions for positive symptoms in schizophrenia: protocol for a network meta-analysis of randomised controlled trials
    Irene Bighelli, Georgia Salanti, Cornelia Reitmeir, Sofia Wallis, Corrado Barbui, Toshi A. Furukawa, Stefan Leucht · 2018 · BMJ Open
79. Mirtazapine adjunct for people with schizophrenia
    Luke Alastair Perry, Dhruvesh M. Ramson, Suzanne Martin Stricklin · 2018 · Cochrane Database of Systematic Reviews
80. Introduction to health measurement scales
    David L. Streiner, Geoffrey R. Norman, John Cairney · 2024
81. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia
    James Sampford, Stephanie J Sampson, Bao Guo Li, Sai Zhao, Jun Xia, Vivek A Furtado · 2016 · Cochrane Database of Systematic Reviews
82. Crisis intervention for people with severe mental illnesses
    CB Joy, CE Adams, Karl Rice · 2004 · Cochrane Database of Systematic Reviews
83. Atypical antipsychotics for psychosis in adolescents
    Ajit Kumar, Soumitra Shankar Datta, Stephen Wright, Vivek A Furtado, Paul Swamidhas Sudhakar Russell · 2012 · Cochrane Database of Systematic Reviews
84. Family-based interventions versus standard care for people with schizophrenia
    Wai Tong Chien, Dennis Chak Fai Ma, Daniel Thomas Bressington, Huanyu Mou · 2024 · Cochrane Database of Systematic Reviews
85. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms
    Michael W Huang, Roger Carl Gibson, Mahesh Jayaram, Stanley N. Caroff · 2022 · Cochrane Database of Systematic Reviews
86. Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studies.
    Spyridon Siafis, Robert Ali McCutcheon, Virginia Chiocchia, Edoardo Giuseppe Ostinelli, Simonne Lesley Wright, Claire Stansfield, Damian Omari Juma, Ioannis Mantas, Oliver David Howes, Grazia Rutigliano et al. · 2023 · Wellcome Open Research
87. Calcium channel blockers for antipsychotic-induced tardive dyskinesia
    Adib Essali, Karla Soares‐Weiser, Hanna Bergman, Clive Elliott Adams · 2018 · Cochrane Database of Systematic Reviews
88. Haloperidol discontinuation for people with schizophrenia
    Adib Essali, Khaled Turkmani, Shaimaa Aboudamaah, Alaa AbouDamaah, Mohammad Reyad Dia'a Aldeen, Mohamad Essam Marwa, Nawar Almounayer · 2019 · Cochrane Database of Systematic Reviews
89. Patient-reported outcomes and outcome measures in childbirth perineal trauma research: a systematic review
    Stergios K. Doumouchtsis, Jemina Loganathan, John Fahmy, Gabriele Falconi, Maria Patricia Rada, Abdullatif Elfituri, Jorge Milhem Haddad, Vasilios Pergialiotis, Cornelia Betschart · 2021 · International Urogynecology Journal
90. Zuclopenthixol dihydrochloride for schizophrenia
    Ajit Kumar, Daniel Strech · 2005 · Cochrane Database of Systematic Reviews
91. Acute stroke: evaluation and treatment.
    Mukesh Kumar Sharma, Heather D. Clark, Trygve Armour, Grant Stotts, Robert Côté, Michael D. Hill, Andrew M. Demchuck, David Moher, Chantelle Garritty, Fatemeh Yazdi et al. · 2005 · PubMed Central
92. Haloperidol versus first generation antipsychotics for schizophrenia
    Markus Dold, Chunbo Li, Magdolna Tardy, Stefan Leucht · 2012 · Cochrane Database of Systematic Reviews
93. Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
    Kumar B Saha, Stephanie J Sampson, Rashid Uz Zaman · 2013 · Cochrane Database of Systematic Reviews
94. Drama therapy for schizophrenia or schizophrenia-like illnesses
    Rachel Ruddy, K Dent-Brown · 2005 · Cochrane Database of Systematic Reviews
95. Day centres for severe mental illness
    Jocelyn Catty, T Burns, Adelina Comas · 2001 · Cochrane Database of Systematic Reviews
96. Psychoeducation (brief) for people with serious mental illness
    Jun Xia, Sai Zhao, Mahesh Jayaram · 2013 · Cochrane Database of Systematic Reviews
97. Physical health care monitoring for people with serious mental illness
    Graeme E Tosh, Andrew Clifton, Shereen Mala, Mick Bachner, Richard John Gray · 2010 · Cochrane Database of Systematic Reviews
98. Omega-3 fatty acids for bipolar disorder
    Paul Montgomery, Richardson Aj, M.A. Ross · 2004 · Cochrane Database of Systematic Reviews
99. Zotepine versus other atypical antipsychotics for schizophrenia
    Katja Komossa, Christine Rummel‐Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Werner Kissling, Stefan Leucht · 2010 · Cochrane Database of Systematic Reviews
100. Atypical Antipsychotics for Tourette's Syndrome
     Anita Pierce, Hugh Edward Rickards · 2009 · Cochrane Database of Systematic Reviews